Zobrazeno 1 - 10
of 27
pro vyhledávání: '"E. S. Abirova"'
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 17, Iss 4, Pp 95-102 (2018)
Atherosclerosis and osteoporosis until recently were regarded as the diseases of modern society, and their simultaneous development was explained just by the increased chances with longevity. Currently, there are studies showing evidence on these dis
Externí odkaz:
https://doaj.org/article/dc59963c86b94b5fbbcdb0138a2f4e0e
Autor:
N. A. Alikhanova, I. A. Skripnikova, O. N. Tkacheva, E. S. Abirova, V. E. Novikov, L. M. Murashko, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 15, Iss 2, Pp 51-56 (2016)
Aim. To study relation of vessel wall stiffness parameters and subclinical atherosclerosis with mineral density of bone (MDB) in postmenopausal women.Material and methods. Into a simultaneous study were included 107 patients at the age 45-82 y.o., be
Externí odkaz:
https://doaj.org/article/29064e662e854b11bdb9b7d65a995be3
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 5, Pp 67-72 (2016)
Results of studies devoted to effects of various antihypertensive drugs on arterial stiffness in patients with arterial hypertension are presented. Advantages of angiotensin converting enzyme inhibitors and angiotensin receptor blockers are shown. Re
Externí odkaz:
https://doaj.org/article/2ebb6001ad2b430cb4a7159598236d28
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 13, Iss 5, Pp 83-93 (2014)
The review concerns on the common pathogenetic mechanisms of the atherosclerosis and osteoporosis development, and vessel wall elasticity with the decrease of bone mass and changes in bone metabolism. In addition, the results of clinical trials are s
Externí odkaz:
https://doaj.org/article/c827cd190d0c4626ba4ed62c036d65d3
Publikováno v:
КардиоСоматика, Vol 2, Iss 1-1 (2011)
Считается, что ингибиторы ангиотензин-превращающего фермента оказывают более благоприятное влияние на жесткость артерий у больных с а
Externí odkaz:
https://doaj.org/article/31c96a0a264d4600bc71be7040be23ed
Publikováno v:
Терапевтический архив, Vol 89, Iss 12-2, Pp 190-196 (2017)
To evaluate the efficiency and safety of long-term Prolia therapy in patients with postmenopausal osteoporosis (OP).The open prospective study enrolled 98 women (mean age, 68±9 years; mean menopause duration, 17±4 years) with postmenopausal OP, who
Autor:
V E Novikov, Olga N. Tkacheva, N. V. Sharashkina, V A Vygodin, E S Abirova, L M Murashko, N A ALIKhANOVA, O. Yu. Isaykina, I. A. Skripnikova
Publikováno v:
Остеопороз и остеопатии, Vol 18, Iss 3, Pp 13-17 (2015)
Objective: to examine the relationship between bone mineral density (BMD), the parameters of vascular stiffness and biomarkers of cellular aging in postmenopausal women. Materials and Methods: In a cross-sectional study107 patients were included: wom
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 1, Pp 39-42 (2014)
В статье проведен анализ методических факторов, влияющих на точность и воспроизводимость измерения минеральной плотности кости методо
Autor:
I. A. Skripnikova, E S Abirova, K. E. Sobchenko, V. E. Novikov, A. V. Smirnov, Tatiana Popkova, I. S. Dydykina, V. A. Vygodin
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 1, Pp 3-7 (2014)
Objective: To investigate the effect of treatment with betablockers (β-AB), inhibitors of angiotensin converting enzyme (ACEI) on bone mineral density (BMD) depending on the risk factors (RF) of osteoporosis. Material and methods. In a retrospective
Publikováno v:
Остеопороз и остеопатии, Vol 16, Iss 1, Pp 35-38 (2013)
This review presents the current data on the pleiotropic effects of beta-blockers in particular on the effect on bone mass and fracture development by means of increased bone fragility. In this article we discuss the mechanisms of action of beta-bloc